Patent · US Active

Substituted isoquinoline and isoquinolinone derivatives

US8772492B2 · kind B2 · utility

0Cited by

4References

48Claims

0Family size

Assignee

Sanofi · FR

Inventors

Oliver Plettenburg · Kelkheim, DE
Katrin Lorenz · Frankfurt am Main, DE
Jochen Goerlitzer · Frankfurt am Main, DE
Matthias Löhn · Frankfurt am Main, DE

Key dates

Filing date	Jun 18, 2009
Grant date	Jul 8, 2014
Priority date	—
Expiry date	Dec 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D451/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 6-substituted isoquinoline and isoquinoline derivatives of the formula (I)useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.